Evidence map›Paper›PMID 36355855›Full record

Observational studyPloS one2022

The longitudinal association between patient empowerment and patient-reported outcomes: What is the direction of effect?

Mariela Acuña Mora, Carina Sparud-Lundin, Eva Fernlund, Shalan Fadl, Kazamia Kalliopi, Annika Rydberg, Åsa Burström, Katarina Hanseus, Philip Moons, Ewa-Lena Bratt

Erratum issuedOpen access · goldAbstract readObservational Study
In one paragraph

Observational study in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 3 countries.

Mariela Acuña MoraInstitute of Health and Care Sciences, University of Gothenburg, Gothenburg, Sweden.ORCID 0000-0002-9326-6339
Carina Sparud-LundinInstitute of Health and Care Sciences, University of Gothenburg, Gothenburg, Sweden.
Eva FernlundDivision of Pediatrics, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Shalan FadlDepartment of Children and Young Adults, University Hospital Örebro, Örebro, Sweden.
Kazamia KalliopiDepartment of Women's and Children's Health, Karolinska Institute, Stockholm, Sweden.
Annika RydbergDepartment of Clinical Sciences, Umeå University, Umeå, Sweden.
Åsa BurströmKarolinska Institute, Department of Neurobiology, Care Sciences and Society, Stockholm, Sweden.
Katarina HanseusChildren's Heart Center, Skåne University Hospital Lund, Lund, Sweden.
Philip MoonsInstitute of Health and Care Sciences, University of Gothenburg, Gothenburg, Sweden.
Ewa-Lena BrattInstitute of Health and Care Sciences, University of Gothenburg, Gothenburg, Sweden.
Karolinska Institutet · SEUniversity of Gothenburg · SEDrottning Silvias barn- och ungdomssjukhus · SELinköping University · SEÖrebro University Hospital · SESkåne University Hospital · SEUmeå University · SEUniversity of Cape Town · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTheoretical literature and cross-sectional studies suggest empowerment is associated with other patient-reported outcomes (PROs). However, it is not known if patient empowerment is leading to improvements in other PROs or vice versa.

aimsThe present study aimed to examine the direction of effects between patient empowerment and PROs in young persons with congenital heart disease (CHD).

methodsAs part of the STEPSTONES-CHD trial, adolescents with CHD from seven pediatric cardiology centers in Sweden were included in a longitudinal observational study (n = 132). Data were collected when patients were 16 (T0), 17 (T1) and 18 ½ years old (T2). The Gothenburg Young Persons Empowerment Scale (GYPES) was used to measure patient empowerment. Random intercepts cross-lagged panel models between patient empowerment and PROs (communication skills; patient-reported health; quality of life; and transition readiness) were undertaken.

resultsWe found a significant cross-lagged effect of transition readiness over patient empowerment between T1 and T2, signifying that a higher level of transition readiness predicted a higher level of patient empowerment. No other significant cross-lagged relationships were found.

conclusionFeeling confident before the transition to adult care is necessary before young persons with CHD can feel in control to manage their health and their lives. Clinicians interested in improving patient empowerment during the transitional period should consider targeting transition readiness.

Indexed as

Heart Defects, CongenitalPatient ParticipationAdolescentAdultChildCross-Sectional StudiesHumansPatient Reported Outcome MeasuresQuality of Life

Identifiers

PMID36355855
PMCPMC9648754
OpenAlexW4308701147

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.